← FDA Drug Approvals (Drugs@FDA)

SELEGILINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2019-04-02

Drug application

FDA Application #
ANDA206803
Application type
Abbreviated New Drug Application (Generic)
Brand name
SELEGILINE HYDROCHLORIDE
Generic name
SELEGILINE HYDROCHLORIDE
Active ingredients
SELEGILINE HYDROCHLORIDE
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
RISING
Manufacturer
Rising Pharma Holdings, Inc.
First approval
2019-04-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown